FDA OKs Ariad's Drug for Two Rare Blood Cancers

Published January 2, 2013

FDA OKs Ariad's drug for two rare blood cancers

Filed under: Drug Treatment Chicago

The approval covers use of the drug, also known as ponatinib, to treat chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia, two types of rare blood and bone marrow cancers, in patients who had been treated with …
Read more on Chicago Tribune

Three Small Cap Stocks Sinking Fast Ahead of the New Year: GSAG, CTIX …

Filed under: Drug Treatment Chicago

Cellceutix also owns the rights to seven other drug compounds, including KM-133 (which is being developed for psoriasis) and KM-391 (for the treatment of the core symptoms of autism). According to … However, it was recently announced that Aspire …
Read more on SmallCap Network